Epirus expands biosimilar pipeline and capabilities
Epirus Biopharmaceuticals, Inc., announced an agreement for the acquisition of Bioceros Holding B.V., enabling Epirus to expand its biosimilar pipeline and vertically integrate product development ...Intas launches Razumab, the first biosimilar to Lucentis
Intas Pharmaceuticals has launched Razumab™, its biosimilar to Lucentis® (Ranibizumab). Intas is the first company globally to develop and launch a biosimilar version of Ranibizumab. Razumab is ...FDA approves first biosimilar Zarxio (filgrastim-sndz) from Sandoz
Sandoz, a Novartis company, announced that the US Food and Drug Administration (FDA) approved Zarxio (filgrastim-sndz) for all indications included in the reference product’s label. Sandoz is the first ...
Medizone Germany GmbH · Keltenring 15 · 82041 Oberhaching · Germany · Phone +49(0)89/12112636 · Fax +49(0)89/12112637 · Impressum · Datenschutz · Imprint · Privacy Policy